Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Iridex Corp changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of IRIX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders2827−1
Shares3.33M3.23M−100.9K (−3.0%)
Value$5.83M$5.43M−$393.7K (−6.8%)

New holders (1)

Institutions that held Iridex Corp at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IRIX in Q4 2024
InstitutionSharesValue% of portfolio
Truist Financial Corp12,979$31.1K0.00%

Sold out (2)

Institutions that held Iridex Corp at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IRIX in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Morgan Stanley1,000$1.75K
Advisor Group Holdings, Inc.1,000$1.75K